Fingerprint
Dive into the research topics of 'A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically